No data to show
XNAS
ZJYL
Market cap94mUSD
Jul 14, Last price
0.60USD
1D
-5.97%
1Q
-29.20%
IPO
51.70%
Name
Jin Medical International Ltd
Chart & Performance
P/E
25.63
P/S
4.01
EPS
0.02
Div Yield, %
—
Shrs. gr., 5y
81.25%
Rev. gr., 5y
2.90%
Revenues
24m
+18.57%
Net income
4m
+27.71%
CFO
-1m
L
Profile
Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | |
| Income | |||||||
Revenues | 23,502 18.57% | 19,821 3.29% | 19,191 -7.58% | ||||
Cost of revenue | 19,863 | 16,954 | 17,060 | ||||
Unusual Expense (Income) | |||||||
NOPBT | 3,639 | 2,867 | 2,131 | ||||
NOPBT Margin | 15.48% | 14.47% | 11.10% | ||||
Operating Taxes | 764 | 344 | 36 | ||||
Tax Rate | 20.99% | 11.99% | 1.69% | ||||
NOPAT | 2,875 | 2,524 | 2,094 | ||||
Net income | 3,676 27.71% | 2,878 6.34% | 2,707 2.84% | ||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | 312 | 8,000 | |||||
BB yield | -0.07% | -94.22% | |||||
| Debt | |||||||
Debt current | 11,508 | 4,113 | |||||
Long-term debt | 378 | ||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | (14,872) | (12,585) | (6,204) | ||||
| Cash flow | |||||||
Cash from operating activities | (1,207) | 3,106 | 1,581 | ||||
CAPEX | (145) | (114) | (40) | ||||
Cash from investing activities | (9,514) | (7,730) | (121) | ||||
Cash from financing activities | 11,654 | 6,911 | 122 | ||||
FCF | 919 | (1,016) | 2,270 | ||||
| Balance | |||||||
Cash | 26,757 | 16,698 | 7,069 | ||||
Long term investments | (865) | ||||||
Excess cash | 25,582 | 15,707 | 5,245 | ||||
Stockholders' equity | 21,803 | 17,542 | 15,156 | ||||
Invested Capital | 18,353 | 12,385 | 9,743 | ||||
ROIC | 18.71% | 22.81% | 21.13% | ||||
ROCE | 9.06% | 10.21% | 14.22% | ||||
| EV | |||||||
Common stock shares outstanding | 156,474 | 7,257 | 8,000 | ||||
Price | 2.69 129.91% | 1.17 | |||||
Market cap | 420,915 4,857.48% | 8,491 | |||||
EV | 405,780 | (4,095) | |||||
EBITDA | 3,985 | 3,093 | 2,493 | ||||
EV/EBITDA | 101.83 | ||||||
Interest | |||||||
Interest/NOPBT | |||||||